BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Drug Development

  Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study

  Data from the study will be submitted to the FDA in support of Market Clearance for TIGERTRIEVER in the U.S.

  May 16, 2018

   · 

  1 min read
• Biotech Beach

  Amgen Receives European Commission Approval For Repatha® (Evolocumab) To Prevent Heart Attack And Stroke In Adults With Established Cardiovascular Disease

  Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved a new indication in the Repatha® (evolocumab)

  May 16, 2018

   · 

  21 min read
• Job Trends

  Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development

  Breakthrough platform optimizes productivity and expands cryo-EM entry path for a broader range of researchers

  May 16, 2018

   · 

  2 min read
• FDA

  Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug

  A powerful, real-world evidence study designed by McKesson Specialty Health for its biopharma partner played a key role in the Food and Drug Administration’s (FDA) approval for first-line indication for a rare disease.

  May 16, 2018

   · 

  3 min read
• Business

  BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common Medical Conditions

  BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell based therapies based on Biolaminins, human recombinant laminin cell culture matrices, developed and produced by BioLamina.

  May 16, 2018

   · 

  2 min read
• Business

  TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform

  Welcomes Renowned Thought Leaders Dr. Malcolm Brenner, Dr. Helen Heslop, and Dr. Cliona Rooney

  May 16, 2018

   · 

  8 min read
• Genetown

  Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio

  Name Change Reflects Company’s Focus on Late-Stage Oncology Drug Development

  May 16, 2018

   · 

  7 min read
• FDA

  Eagle Pharmaceuticals, Inc. Granted Final FDA Approval for Bendamustine Hydrochloride Ready-to-Dilute Solution in a 500ml Admixture

  Eagle to ship 500ml admixture product immediately

  May 16, 2018

   · 

  3 min read
• Business

  GeneNews Announces Q1 2018 Results and Provides Progress Update

  Number of enrolled and active practices continues to grow

  May 16, 2018

   · 

  4 min read
• Business

  Glassbeam Signs RES as a Strategic Reseller and Scripps Health as Customer Deployment

  Agreement Combines Glassbeam Analytics with Reseller RES’s Domain Expertise at Scripps

  May 16, 2018

   · 

  3 min read